Semaglutide Therapy
(Initial Dose)
$300.00 (Initial Dose)
Semaglutide is a glucagon-like peptide-1 (GLP-1) analog that was approved in 2020 as a treatment method for improving glycemic control in patients with Type 2 diabetes. Semaglutide shows great promise for patients who are having difficulty losing weight.
Studies have demonstrated that Semaglutide reduced appetite, improved control of eating, and reduced food cravings in addition to improved glycemic control.
How does Semaglutide + B12 work?
GLP-1 is a hormone produced in the small intestine that stimulates insulin secretion and inhibits glucagon secretion, thereby lowering blood sugar.
Semaglutide + B12 has demonstrated beneficial effects on glycemia, in addition to a host of other benefits.
Benefits:
• Weight Loss
• Neuroprotective
• Improved Fertility
• Treatment of PCOS
• Smoking Cessation
• Cardiovascular Benefits
How should Semaglutide + B12 be used?
Semaglutide + B12 is applied as a subcutaneous which is most commonly dosed at .05ml(0.25mg) to 0.5mL(1mg) once weekly. This dosing may be increased to 1mL(2mg) once weekly after one month of treatment if needed.
This medication is generally well-tolerated and can be dosed continuously without breaking treatment with no diminishing effects.
Side effects/contraindications
The most commonly reported side effects include nausea, vomiting, diarrhea, stomach pain, and constipation. The risk of serious side effects increases in patients with hypoglycemia, kidney problems, and risk of allergic reactions.
